Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLNR | O43193 | 1/20 | 0.83 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.83 |
| ▸ | PGR | P06401 | 1/20 | 0.83 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.83 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.83 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.83 |
| ▸ | DRD2 | P14416 | 1/20 | 0.83 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.83 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.83 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.83 |
| ▸ | CNR1 | P21554 | 1/20 | 0.83 |
| ▸ | DRD1 | P21728 | 1/20 | 0.83 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.83 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.83 |
| ▸ | HRH2 | P25021 | 1/20 | 0.83 |
| ▸ | HTR2C | P28335 | 1/20 | 0.83 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.83 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.83 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.83 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL249681 | 1.00 | MLNR (0.83) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL16813068 | 0.99 | MLNR (0.84) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL17958827 | 0.95 | MLNR (0.81) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL13749987 | 0.95 | MLNR (0.81) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL14597388 | 0.95 | BLM (0.75) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL13657407 | 0.95 | BLM (0.75) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL19569765 | 0.94 | MLNR (0.83) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL16597109 | 0.94 | CHRM1 (0.83) | MLNRNR1I2PGRADRB1ADORA3 | |
| SCHEMBL17658757 | 0.94 | CHRM1 (0.83) | MLNRNR1I2PGRADRB1ADORA3 | |
| Bromide SCHEMBL31621175 | 0.94 | BLM (0.74) | MLNRNR1I2PGRADRB1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180099057-A1 | NANOPLATFORMS FOR ARGINASE, INDOLEAMINE 2,3-DIOXYGENASE AND TRYPTOPHAN 2,3-DIOXYGENASE DETECTION BY POSTTRANSLATIONAL MODIFICATION | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | 2018-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180099057-A1 | NANOPLATFORMS FOR ARGINASE, INDOLEAMINE 2,3-DIOXYGENASE AND TRYPTOPHAN 2,3-DIOXYGENASE DETECTION BY POSTTRANSLATIONAL MODIFICATION | IDO2, IDO1, ARG1 | MLNR 816/4885NR1I2 3237/4885PGR 4435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.